切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (06) : 649 -656. doi: 10.3877/cma.j.issn.1673-5250.2023.06.005

论著

先天性甲状腺功能减退症患儿确诊时间的影响因素分析
姜舟1, 唐立2,(), 杨柳2, 邹凌1   
  1. 1. 电子科技大学医学院附属妇女儿童医院·成都市妇女儿童中心医院新生儿疾病筛查科,成都 611731
    2. 电子科技大学医学院附属妇女儿童医院·成都市妇女儿童中心医院保健部,成都 611731
  • 收稿日期:2023-06-20 修回日期:2023-11-10 出版日期:2023-12-01
  • 通信作者: 唐立

Analysis of influencing factors of diagnosis time in infants with congenital hypothyroidism

Zhou Jiang1, Li Tang2,(), Liu Yang2, Lin Zou1   

  1. 1. Department of Neonatal Screening, Chengdu Women′s and Children′s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, Sichuan Province, China
    2. Department of Health Care, Chengdu Women′s and Children′s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, Sichuan Province, China
  • Received:2023-06-20 Revised:2023-11-10 Published:2023-12-01
  • Corresponding author: Li Tang
  • Supported by:
    Project of Statistical Information Center of National Health Commission(2019YFC1005104Z2104)
引用本文:

姜舟, 唐立, 杨柳, 邹凌. 先天性甲状腺功能减退症患儿确诊时间的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 649-656.

Zhou Jiang, Li Tang, Liu Yang, Lin Zou. Analysis of influencing factors of diagnosis time in infants with congenital hypothyroidism[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 649-656.

目的

探讨先天性甲状腺功能减退症(CH)患儿确诊时间的影响因素。

方法

选取2016年1月1日至2021年12月31日在成都市所有助产机构出生的促甲状腺激素(TSH)初筛结果为CH阳性或可疑阳性,并且成功召回复查的11 689例活产新生儿为研究对象。将其中679例确诊为CH患儿,根据确诊时间,分别纳入早诊CH组(n=467,生后≤30 d确诊者)与晚诊CH组(n=212,生后>30 d确诊者)。采用χ2检验与Wilcoxon秩和检验,比较2组患儿性别、是否为足月儿、出生季节,出生医院所在区域、性质与级别,是否在出生医院采集第2次足跟血进行复查,以及滤纸片干血斑标本(DBS)检测前周转时间、DBS检测报告周转时间、CH初筛可疑阳性患儿被召回时间。对这11 689例受试儿,绘制血清TSH水平初筛值预测其发生CH的受试者工作特征(ROC)曲线,并计算曲线下面积(AUC)与约登指数,分析血清TSH水平初筛值对患儿发生CH的预测价值。本研究遵循的程序符合电子科技大学医学院附属妇女儿童医院·成都市妇女儿童中心医院伦理委员会制定的伦理学标准,并得到该伦理委员会批准[审批文号:科研伦审2021(41)号)]。

结果

①早诊CH组和晚诊CH组患儿性别、是否为足月儿、出生季节、出生医院性质及级别构成比等分别比较,差异均无统计学意义(P>0.05)。2组患儿出生医院所在区域及是否在出生医院采集第2次足跟血进行复查比较,差异均有统计学意义(χ2=26.39、125.80,P<0.001)。②早诊CH组患儿DBS检测前周转时间、DBS检测报告周转时间、CH初筛可疑阳性患儿被召回时间分别为11 d(9 d,14 d),6 d(5 d,7 d),3 d(1 d,7 d),均显著短于晚诊CH组的14 d(11 d,18 d),7 d(6 d,7 d),11 d(8 d,15 d),并且差异均有统计学意义(Z=-8.02、P<0.001,Z=-2.61、P=0.009,Z=-15.35、P<0.001)。③对11 689例受试儿绘制血清TSH水平初筛值预测其发生CH的ROC曲线结果显示,其AUC为0.871(95%CI:0.825~0.886,P<0.001),根据约登指数最大原则,血清TSH水平初筛值预测患儿发生CH的最佳临界值为14.7 μIU/mL,此时其预测患儿发生CH的敏感度为69.1%,特异度为93.4%,约登指数为62.5%。

结论

CH新生儿出生医院位于郊区、CH初筛可疑阳性患儿被召回时间及DBS检测前周转时间长,可能造成CH确诊时间延误。成都市卫生行政部门应针对上述因素采取相应措施,缩短CH患儿确诊时间。建议将血清TSH水平初筛值14.7 μIU/mL作为CH筛查阳性临界值,可能更有利于缩短CH患儿确诊时间。

Objective

To explore the influencing factors of diagnosis time in infants with congenital hypothyroidism (CH).

Methods

A total of 11 689 live-born infants born in all midwifery institutions in Chengdu from January 1, 2016, to December 31, 2021, with positive or suspicious positive CH in initial thyroid stimulating hormone (TSH) screening and successfully recalled for re-examination were selected as the study subjects. Among them, 679 children with confirmed CH were divided into early-diagnosed CH group (n=467, diagnosed as CH ≤ 30 d after birth) and late-diagnosed CH group (n=212, diagnosed as CH > 30 d after birth). Chi-square test and Wilcoxon rank sum test were used to compare the gender, full-term delivery, birth season, location area, ownership and accreditation level of the birth hospital, whether the second blood spot sample for re-examination was collected at the birth hospital, as well as the turnaround time of dried blood spots on filter paper (DBS) before test, turnaround time of test report of DBS, and recall time for children with suspicious positive CH in CH initial screening. Among 11 689 infants, the receiver operating characteristic (ROC) curve of initial screening value of serum TSH was plotted to predict the risk of CH, and the area under curve (AUC) and Youden index were calculated to analyze the predictive value of initial screening value of serum TSH for the occurrence of CH. The procedures followed in this study complied with the ethical standards established by the Ethics Committee of Chengdu Women′s and Children′s Central Hospital, University of Electronic Science and Technology of China, and have been approved by the Ethics Committee [Approval No. 2021(41)].

Results

① There were no significant differences in gender, full-term delivery, birth season, the ownership and accreditation level of birth hospital between early- and late-diagnosed CH group (P>0.05). The differences in location area of birth hospital, and whether the second blood spot sample for re-examination was collected at the birth hospital between two groups were statistically significant (χ2=26.39, 125.80; P<0.001). ②The turnaround time of DBS before test, turnaround time of test report of DBS, and recall time for children with suspicious positive CH in CH initial screening was 11 d (9 d, 14 d), 6 d (5 d, 7 d), and 3 d (1 d, 7 d) respectively in early-diagnosed CH group, all of which were shorter than those of late-diagnosed CH group at 14 d (11 d, 18 d), 7 d (6 d, 7 d), 11 d (8 d, 15 d), and all the differences were statistically significant (Z=-8.02, P<0.001; Z=-2.61, P=0.009; Z=-15.35, P<0.001). ③Among the 11 689 infants, result of ROC curve of initial screening value of serum TSH to predict CH in infants showed that the AUC was 0.871 (95%CI: 0.825-0.886, P<0.001). Based on the principal of maximum Youden index, the optimal cut-off value of initial screening value of serum TSH for predicting CH in infants was 14.7 μIU/mL, and the sensitivity, specificity and Youden index were 69.1%, 93.4% and 62.5%, respectively.

Conclusions

Infants with CH born in suburban hospital, with a longer recall time for suspicious positive CH in CH initial screening, and with a longer turnaround time of DBS before test may cause delay in the diagnosis of CH. Chengdu municipal health administrations should take corresponding measures for the above factors and shorten the time for diagnosing CH children. It is suggested to take the initial screening value of serum TSH 14.7 μIU/mL as the positive cut-off value for CH screening may be more conducive to shortening the time for diagnosing children with CH.

表1 2组患儿相关临床资料比较[例数(%)]
表2 2组患儿CH筛查不同阶段所花费时间比较[d,M(Q1Q3)]
表3 2组中,在出生医院采集第2次足跟血进行复查患儿的CH筛查不同阶段所花费时间比较[d,M(Q1Q3)]
图2 血清TSH水平初筛值预测患儿发生CH的ROC曲线 注:TSH为促甲状腺激素,ROC曲线为受试者工作特征曲线,AUC为曲线下面积
[1]
Vigone MC, Caiulo S, Di Frenna M, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism[J]. J Pediatr, 2014, 164(6): 1296-1302. DOI: 10.1016/j.jpeds.2013.12.048.
[2]
中华医学会儿科学分会内分泌遗传代谢学组,中华预防医学会儿童保健分会新生儿疾病筛查学组. 先天性甲状腺功能减低症诊疗共识[J]. 中华儿科杂志2011, 49(6): 421-424. DOI: 10.3760/cma.j.issn.0578-1310.2011.06.006.
[3]
吴雄基. 影响先天性甲状腺功能减退症替代治疗患儿预后的相关因素[J]. 中外医学研究2021, 19(8): 135-137. DOI: 10.14033/j.cnki.cfmr.2021.08.050.
[4]
熊丰. 新生儿先天性甲状腺功能减低症的诊断和治疗[J]. 实用儿科临床杂志2012, 27(8): 642-644. DOI: 10.3969/j.issn.1003-515X,2012.08.030.
[5]
卫生部. 新生疾病筛查技术规范(2010年版)[EB/OL]. (2010-11-10) [2023-04-20].

URL    
[6]
国家卫生计生委临床检验中心新生儿遗传代谢病筛查实验室专家组. 新生儿遗传代谢病筛查质量指标共识[J]. 中华检验医学杂志2017, 40(5): 352-355. DOI: 10.3760/cma.j.issn.1009-9158.2017.05.005.
[7]
Omuse G, Kassim A, Kiigu F, et al. Reference intervals for thyroid stimulating hormone and free thyroxine derived from neonates undergoing routine screening for congenital hypothyroidism at auniversity teaching hospital in Nairobi, Kenya: a crosssectionalstudy[J]. BMC Endocr Disord, 2016, 16(1): 23-30. DOI: 10.1186/s12902-016-0107-9.
[8]
姜舟,赖婷,李晓丽,等. 成都市2011—2021年新生儿遗传代谢病筛查结果分析及30年筛查变化情况分析[J]. 中国优生与遗传杂志2023, 31(5): 885-890. DOI: 10.13404/j.cnki.cjbhh.2023.05.002.
[9]
Horn S, Heuer H. Thyroid hormone action during brain development: more questions than answers[J]. Mol Cell Endocrinol, 2010, 315(1): 19-26. DOI: 10.1016/j.mce.2009.09.008.
[10]
Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings[J]. J Neuroendocrinol, 2004, 16(10): 809-818. DOI: 10.1111/j.1365-2826.2004.01243.x.
[11]
王德承. 先天性甲状腺功能减低症患儿骨龄的影响因素分析[J]. 泰山医学院学报2015, 36(3): 346-347. DOI: 10.3969/j.issn.1004-7115.2015.03.048.
[12]
严学勤,曾洁,上官予梅,等. 先天性甲状腺功能减退症患儿生长发育相关因素研究[J]. 中国妇幼保健2018, 33(3): 612-614. DOI: 10.7620/zgfybj.j.issn.1001-4411.2018.03.45.
[13]
李中会,程昕然,苟鹏,等. 不同治疗时机对先天性甲状腺功能减退症患儿体格、智力及神经系统发育的影响[J]. 解放军医药杂志2022, 34(1): 44-47. DOI: 10.3969/j.issn.2095-140X.2022.01.009.
[14]
高苗苗,范惠霞,阎亚琼. 不同初始治疗时机对先天性甲状腺功能减退症患儿的治疗效果分析[J]. 广东医学2019, 40(8): 1104-1108. DOI: 10.13820/j.cnki.gdyx.20186003.
[15]
宋怀东,韩兵. 先天性甲状腺功能减退症患儿的诊治[J]. 中国实用内科杂志2021, 41(2): 112-115. DOI: 10.19538/j.nk2021020106.
[16]
王颖,黄太华,牟鸿江,等. 2 982例新生儿疾病筛查可疑阳性病例召回情况分析[J]. 中国妇幼保健2022, 37(2): 326-329. DOI: 10.19829/j.zgfybj.issn.1001-4411.2022.02.042.
[17]
李蓓,贾雪芳,陈倩瑜,等. 2009年-2012年广州地区新生儿筛查可疑阳性未召回原因分析及对策[J].中国优生与遗传杂志2015, 23(2): 73-74. DOI: 10.13404/j.cnki.cjbhh.2015.02.037.
[18]
刘玉皎,李利霞. 先天性甲状腺功能减退症患儿父母疾病认知度及治疗依从性调查[J]. 社区医学杂志2020, 18(3): 392-394. DOI: 10.19790/j.cnki.JCM.2020.06.02.
[19]
La Franchi SH. Screening preterm infants for congenitalhypothyroidism: better the second time around[J]. J Pediatr, 2014, 164(6): 1259-1261. DOI: 10.1016/j.jpeds.2014.02.031.
[20]
姜舟,王梅,唐立,等. 成都市54 025例早产儿葡萄糖-6-磷酸脱氢酶缺乏症筛查结果及分子遗传学特征分析[J]. 中国当代儿科杂志2021, 23(5): 482-487. DOI: 10.7499/j.issn.1008-8830.2012012.
[21]
赵金琦,马志军,杨海河,等. 北京市350万例新生儿疾病筛查工作质量分析[J]. 中国妇幼健康研究2023, 34(2): 104-109. DOI: 10.3969/j.issn.1673-5293.2023.02.021.
[22]
刘鸿丽,李风侠. 2010—2016年陕西省新生儿疾病筛查治疗及随访结果分析[J]. 中国儿童保健杂志2018, 26(11): 1221-1223. DOI: 10.11852/zgetbjzz2018-26-11-16.
[23]
李霞,何玲,厉玉姣. 长沙地区2016—2018年新生儿疾病筛查结果回顾性分析[J]. 中国卫生标准管理2020, 11(16): 3-6. DOI: 10.3969/j.issn.1674-9316.2020.16.002.
[24]
李晓丽,王梅,李惠,等. 成都市19年新生儿疾病筛查回顾性分析[J]. 四川医学2012, 33(8): 1474-1477. DOI: 10.16252/j.cnki.issn1004-0501-2012.08.069.
[1] 高玲, 于哲, 范然, 臧银善. 外周血细胞计数比值评估类风湿关节炎疗效的价值[J]. 中华关节外科杂志(电子版), 2023, 17(05): 642-647.
[2] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[3] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[4] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[5] 杨莹, 刘艳, 王央丹. 新生儿结节性硬化症相关性癫痫1例并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 464-472.
[6] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[7] 李聪, 徐艳, 吴铭, 丁瑞东, 王军. 极低出生体重儿出生时血清25-羟维生素D水平与其生后早期喂养不耐受关系的临床分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 309-314.
[8] 赵金琦, 杨楠, 宫丽霏, 唐玥, 李璐璐, 杨海河, 孔元原. 2011—2020年北京市小于胎龄儿出生状况分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 278-286.
[9] 王鹏, 肖厚安, 贾赤宇. 不同因素调控巨噬细胞极化在慢性难愈性创面中的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 454-459.
[10] 王本泉, 崔凡, 邱钧, 项本宏. 不同甲状腺手术方式对改善胰岛素抵抗的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 208-211.
[11] 陈静, 王晓玲, 安康. 老年进展期胃癌术后腹膜转移的相关因素及治疗进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 225-228.
[12] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[13] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[14] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[15] 强光峰, 孟兰兰, 赵静, 牛峰海, 任雪云. 肺部超声评分对呼吸困难新生儿使用有创机械通气的预测价值[J]. 中华诊断学电子杂志, 2023, 11(02): 104-108.
阅读次数
全文


摘要